In regulated industries like life sciences, quality and manufacturing have traditionally been built for assurance, not ...

IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that Stacy Lindborg, Ph.D., President and Chief Executive Officer of ...

The possible merger of humans and machines has been a fascination for science fiction writers since the mid-20th century. With the proliferation of co ...

What if you could live forever, staying healthy and young for centuries? Scientists and tech pioneers now believe this dream ...